Analysis of B19 virus contamination in plasma pools for manufacturing, by using a competitive polymerase chain reaction assay

Vox Sanguinis

Volumn 83, Issue 4, 2002, Pages 324-331

  Gallinella, Giorgio ^a   Moretti, E ^b   Nardi, G ^b   Zuffi, E ^a   Bonvicini, F ^a   Bucci, E ^b   Musiani, M ^a   Zerbini, M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Kedrion   (Italy)

Author keywords

B19 virus; Competitive PCR assay; Plasma pools

Indexed keywords

ACCURACY; ARTICLE; CONTROLLED STUDY; LYSIS; NONHUMAN; PARVOVIRUS; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCREENING; VIRAL CONTAMINATION; VIRUS DETECTION; VIRUS LOAD;

BLOOD DONORS; BLOOD TRANSFUSION; CONSUMER PRODUCT SAFETY; DNA, VIRAL; HUMANS; INFECTION CONTROL; MASS SCREENING; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; QUALITY CONTROL;

EID: 6444244993     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.2002.00227.x     Document Type: Article

References (38)

1. Dodd RY: Current viral risks of blood and blood products. Ann Med 2000;32:469-474
2. Tabor E, Yu MY, Hewlett I, Epstein JS: Summary of a workshop on the implementation of NAT to screen donors of blood and plasma for viruses. Transfusion 2000;40:1273-1275
3. Zerbini M, Musiani M: Human parvoviruses; in Murray PR, Baron EJ, Pfaller MA, Tenover FC, Tolken RH (eds). Manual of Clinical Microbiology. Washington, DC, ASM Press, 1999:1089-1098
4. Siegl G, Cassinotti P: Presence and significance of parvovirus B19 in blood and blood products. Biologicals 1998;26:89-94
5. Prowse C, Ludlam CA, Yap PL: Human parvovirus B 19 and blood products. Vox Sang 1997;72:1-10
6. Zakrzewska K, Azzi A, Patou G, Morfini M, Rafanelli D, Pattison JR: Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by the nested polymerase chain reaction. Br J Haematol 1992;81:407-412
7. McOmish F, Yap PL, Jordan A, Hart H, Cohen BJ, Simmonds P: Detection of parvovirus B19 in donated blood: A model system for screening by polymerase chain reaction. J Clin Microbiol 1993;31:323-328
8. Lefrere JJ, Mariotti M, Thauvin M: B19 parvovirus DNA in solvent/detergent-treated anti-haemophilia concentrates. Lancet 1994;343:211-212
9. Saldanha J, Minor P: Detection of human parvovirus B19 DNA in plasma pools and blood products derived from these pools: Implications for efficiency and consistency of removal of B19 DNA during manufacture. Br J Haematol 1996;93:714-719
10. Jordan J, Tiangco B, Kiss J, Koch W: Human parvovirus B19: Prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients. Vox Sang 1998; 75:97-102
11. Mortimer PP, Luban NL, Kelleher JF, Cohen BJ: Transmission of serum parvovirus-like virus by clotting-factor concentrates. Lancet 1983;2:482-484
12. Williams MD, Cohen BJ, Beddall AC, Pasi KJ, Mortimer PP, Hill FG: Transmission of human parvovirus B19 by coagulation factor concentrates. Vox Sang 1990;58:177-181
13. Grosse-Bley A, Eis-Hubinger AM, Kaiser R, Oldenburg J, Brackmann HH, Schwarz TF: Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs. Thromb Haemost 1994;72:503-507
14. Azzi A, Morfini M, Mannucci PM: The transfusion-associated transmission of parvovirus B19. Transfus Med Rev 1999; 13:194-204
15. Horowitz B, Ben-Hur E: Efforts in minimizing risk of viral transmission through viral inactivation. Ann Med 2000;32:475-484
16. Bartolomei Corsi O, Azzi A, Morfini M, Fani R, Rossi Ferrini P: Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates. J Med Virol 1988;25:165-170
17. Azzi A, Ciappi S, Zakvrzewska K, Morfini M, Mariani G, Mannucci PM: Human parvovirus B 19 infection in hemophiliacs first infused with two high-purity, vitally attenuated factor VIII concentrates. Am J Hematol 1992;39:228-230
18. Santagostino E, Mannucci PM, Gringeri A, Azzi A, Morfini M, Musso R, Santoro R, Schiavoni M: Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization. Transfusion 1997;37:517-522
19. Brown KE, Young NS, Barbosa LH: Parvovirus B19: Implications for transfusion medicine. Summary of a workshop. Transfusion 2001;41:130-135
20. Gallinella G, Zerbini M, Musiani M, Venturoli S, Gentilomi G, Manaresi E: Quantitation of parvovirus B19 DNA sequences by competitive PCR: Differential hybridization of the amplicons and immunoenzymatic detection on microplate. Mol Cell Probes 1997;11:127-133
21. Zerbini M, Gallinella G, Manaresi E, Musiani M, Gentilomi G, Venturoli S: Standardization of a PCR-ELISA in serum samples: Diagnosis of active parvovirus B19 infection. J Med Virol 1999; 59:239-244
22. Zerbini M, Musiani M, Venturoli S, Gallinella G, Gibellini D, Gentilomi G, La Placa M: Rapid screening for B19 parvovirus DNA in clinical specimens with a digoxigenin-labeled DNA hybridization probe. J Clin Microbiol 1990;28:2496-2499
23. Girotti S, Musiani M, Pasini P, Ferri E, Gallinella G, Zerbini M, Roda A, Gentiloma G, Venturoli S: Application of a low-light imaging device and chemiluminescent substrates for quantitative detection of viral DNA in hybridization reactions. Clin Chem 1995;41:1693-1697
24. Zanella A, Rossi F, Cesana C, Foresti A, Nador F, Binda AS, Lunghi G, Cappellini MD, Furione M, Sirchia G: Transfusion-transmitted human parvovirus B19 infection in a thalassemic patient. Transfusion 1995;35:769-772
25. Cohen BJ, Beard S, Knowles WA, Ellis JS, Joske D, Goldman JM, Hewitt P, Ward KN: Chronic anemia due to parvovirus B19 infection in a bone marrow transplant patient after platelet transfusion. Transfusion 1997;37:947-952
26. Cohen B, Millar A, Schwind P: Screening blood donations for parvovirus B19. Lancet 1995;346:1631
27. Wakamatsu C, Takakura F, Kojima E, Kiriyama Y, Goto N, Matsumoto K, Oyama M, Sato H, Okochi K, Maeda Y: Screening of blood donors for human parvovirus B19 and characterization of the results. Vox Sang 1999;76:14-21
28. Aubin JT, Defer C, Vidaud M, Maniez Montreuil M, Flan B: Large-scale screening for human parvovirus B19 DNA by PCR: Application to the quality control of plasma for fractionation. Vox Sang 2000;78:7-12
29. Morfini M, Azzi A, Mannucci PM: B19 parvovirus withstands 'super heating' in antihemophilic concentrates. Thromb Haemost 1996;76:821
30. Lyon DJ, Chapman CS, Martin C, Brown KE, Clewley JP, Flower AJ, Mitchell VE: Symptomatic parvovirus B19 infection and heat-treated factor IX concentrate. Lancet 1989;1:1085
31. Morfini M, Longo G, Rossi Ferrini P, Azzi A, Zakrewska C, Ciappi S, Kolumban P: Hypoplastic anemia in a hemophiliac first infused with a solvent/detergent treated factor VIII concentrate: The role of human B19 parvovirus. Am J Hematol 1992;39:149-150
32. Yee TT, Cohen BJ, Pasi KJ, Lee CA: Transmission of symptomatic parvovirus B19 infection by clotting factor concentrate. Br J Haematol 1996;93:457-459
33. Matsui H, Sugimoto M, Tsuji S, Shima M, Giddings J, Yoshioka A: Transient hypoplastic anemia caused by primary human parvovirus B19 infection in a previously untreated patient with hemophilia transfused with a plasma-derived, monoclonal antibody-purified factor VIII concentrate. J Pediatr Hematol Oncol 1999;21:74-76
34. Koenigbauer UF, Eastlund T, Day JW: Clinical illness due to parvovirus B19 infection after infusion of solvent/detergent-treated pooled plasma. Transfusion 2000;40:1203-1206
35. Hino M, Ishiko O, Honda KI, Yamane T, Ohta K, Takubo T, Tatsumi N: Transmission of symptomatic parvovirus B 19 infection by fibrin sealant used during surgery. Br J Haematol 2000; 108:194-195
36. Weimer T, Streichert S, Watson C, Groner A: High-titer screening PCR: A successful strategy for reducing the parvovirus B19 load in plasma pools for fractionation. Transfusion 2001;41:1500-1504
37. Aberham C, Pendl C, Gross P, Zerlauth G, Gessner M: A quantitative, internally controlled real-time PCR assay for the detection of parvovirus B19 DNA. J Virol Methods 2001;92:183-191
38. Daly P, Corcoran A, Mahon BP, Doyle S: High-sensitivity PCR detection of parvovirus B19 in plasma. J Clin Microbiol 2002; 40:1958-1962